1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Intuitive Surgical, Inc.

Intuitive Surgical, Inc.

ISRG.TO
Intuitive Surgical, Inc.CA flagToronto Stock Exchange
20.73
CAD
+0.08
- -
7.32BMarket Cap
Intuitive Surgical, Inc.
ISRG.TO
(Toronto Stock Exchange)

Recent

price

20.73

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.16
0.2
0.24
0.25
0.26
0.29
0.31
0.37
0.44
0.52
0.5
0.64
0.7
0.81
0.94
1.13
1.24
Revenue per Share
0.04
0.06
0.07
0.07
0.05
0.07
0.09
0.08
0.13
0.16
0.12
0.19
0.15
0.2
0.26
0.32
0.35
Basic EPS, GAAP
0.05
0.07
0.08
0.09
0.07
0.09
0.12
0.11
0.12
0.14
0.13
0.2
0.11
0.09
0.15
0.28
0.36
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
5.82
7.48
9.9
10.18
10.26
12.83
16.55
14.18
19.44
23.75
27.56
33.27
31.55
37.77
46.08
50.19
51.34
Book Value per Share
5.3
6.95
9.23
9.6
9.43
12.09
15.88
13.51
18.55
22.54
26.39
32.11
30.41
36.67
45.05
49.12
49.14
Tangible Book Value per Share
8,822
8,822
8,957
9,027
8,305
8,350
8,620
8,380
8,530
8,657
8,777
8,905
8,895
8,782
8,882
8,925
8,868
Basic Weighted Avg Shares
1,413
1,757
2,179
2,265
2,132
2,384
2,706
3,138
3,724
4,478
4,358
5,710
6,222
7,124
8,352
10,065
11,034
Sales/Revenue/Turnover
39.29
39.54
40.3
37.64
25.56
31.04
35.09
33.87
32.21
30.69
24.09
31.89
25.35
24.8
28.12
29.27
31.28
Operating Margin (%)
40
46
58
67
74
90
92
99
123
203
276
310
366
455
500
677
794
Depreciation Expense
382
495
657
671
419
589
738
671
1,128
1,379
1,061
1,705
1,322
1,798
2,323
2,856
3,139
Net Income, GAAP
33.29
30.24
26.55
22.95
23.72
22.37
25.07
39.27
12.08
8.01
11.62
8.58
16.33
7.23
12.58
13.13
17.02
Effective Tax Rate (%)
27.02
28.17
30.14
29.62
19.65
24.69
27.28
21.38
30.29
30.8
24.33
29.85
21.25
25.24
27.81
28.38
28.45
Profit Margin (%)
1,002
1,146
1,491
1,552
1,311
1,704
2,654
2,146
3,513
3,632
5,661
4,695
4,831
6,229
5,366
7,773
7,620
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
87
- -
- -
- -
- -
- -
LT Debt
2,037
2,646
3,580
3,501
3,379
4,320
5,778
4,780
6,688
8,285
9,759
11,952
11,113
13,397
16,530
17,942
18,298
Total Equity
20.75
20.71
20.7
18.53
12.06
14.89
14.03
12.12
18.25
16.82
10.25
15.23
11.35
13.29
13.63
14.75
15.69
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
21.36
21.14
21.09
18.95
12.17
15.3
14.62
12.71
19.69
18.46
11.79
15.76
11.53
14.77
15.62
16.67
17.43
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
355
354
354
Market Capitalization
7,716
6,161
5,161

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
9,780
8,810
9,543
Cash, Cash Equivalents & STI
5,935
4,517
5,216
Accounts Receivable, Net
1,527
1,391
1,433
Inventories
1,840
1,945
2,029
Total Current Liabilities
2,006
1,911
1,923
Payables & Accruals
851
981
948
ST Debt
- -
- -
- -
Deferred Revenue
507
560
549

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
16.6%
13.59%
8.54%
Free Cash Flow
20.57%
30.2%
91.03%
Net Income, GAAP
21%
25.28%
22.97%
Sales/Revenue/Turnover
15.79%
18.44%
20.51%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,891
2,010
2,038
2,414
8,352
2025
2,253
2,440
2,505
2,866
10,065
2026
2,771
2,892
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.06
0.06
0.06
0.08
0.26
2025
0.08
0.07
- -
0.09
0.32
2026
0.09
0.09
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
AVE Science&Technology CO.,LTD (688067.SS)
Dentium Co. Ltd. (145720.KS)
KORU Medical Systems, Inc. (KRMD)
JMS Co.,Ltd. (7702.T)
Micro-Tech (Nanjing) Co., Ltd. (688029.SS)
DENTSPLY SIRONA Inc. (XRAY)
Business
Intuitive Surgical, Inc. develops, manufactures, and markets robotic-assisted surgical systems and minimally invasive care solutions for hospitals and physicians worldwide. Founded in 1995 and headquartered in Sunnyvale, California, the company’s core offerings include the da Vinci surgical platform, including multiport and single-port systems such as da Vinci 5; the Ion endoluminal system for minimally invasive lung biopsy; procedure-specific instruments and accessories; staplers and endoscopic devices; vision and imaging technologies; software and digital workflow tools; and training, service, and support for its installed base. Intuitive serves healthcare providers across the United States and international markets, with clinical use spanning specialties such as urology, gynecology, thoracic surgery, general surgery, and colorectal surgery. In March 2026, the company expanded its European operations by acquiring its distributors in Italy, Spain, and Portugal, establishing direct operations in those markets and adding approximately 250 employees. During 2025, Intuitive obtained FDA clearance for Ion software updates that incorporate artificial intelligence across the navigation workflow and enhance imaging capabilities, cleared SP SureForm 45 staplers for use with the da Vinci SP system in the United States and selected Asian markets, and continued the rollout of da Vinci 5, with system placements and procedure volumes rising materially; full-year 2025 worldwide procedures increased 19%, driven by 18% growth in da Vinci procedures and 51% growth in Ion procedures.